XIX International AIDS Conference. Session on Pediatrics with medical doctors and scientists discussing prevention of mother-to-child transmission and the development of antiretroviral treatments suitable for infants and small children.

XVII International AIDS Conference in Mexico City. Jeffrey Sturchio, Vice President of Merck & Co, talks about the development of protease inhibitors in 1996 and the relationship between the activists and the drug industry.

XVII International AIDS Conference in Mexico City. Jeffrey Sturchio, Vice President of Merck & Co, talks about the development of protease inhibitors in 1996 and the relationship between the activists and the drug industry.

Daria Hazuda from MSD explains the virology of HIV and talks about the past clinical studies on ARV, in particular integrase inhibitors, which she has been involved in. She also reflects on HIV as an exceptional virus and how to influence a new generation of HIV researchers.

XVI International AIDS Conference in Toronto. Panel session on health policy with Swedish AIDS Ambassador Lennart Hjelmåker, UNAIDS Executive Director Peter Piot, Indian Minister of Health Anbunmani Romdass, Sipho Mthathi from TAC and Jeffrey Sturchio from Merck.